VistaGen CEO says on track to deliver ELEVATE topline results before year-end
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
VistaGen CEO sees ELEVATE topline results before year-end
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Salarius Pharmaceuticals Reports Fourth Quarter and Full-Year 2019 Financial Results
Seclidemstat Achieves Dose-Escalation Milestone in Phase 1/2 Ewing Sarcoma Clinical Trial Sixth Level Dosing Cohort Now Proceeding; On Track To Report Topline Data in 2020 HOUSTON, March 23, 2020 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc.....»»
Vaccinex Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
On-track to report topline data from CLASSICAL-Lung and SIGNAL clinical trials this year Announces expansion of pepinemab development program into Alzheimer's disease Completes private placement of c.....»»
VistaGen Therapeutics Reports Fiscal Year 2018 Financial Results and Provides Year-to-Date Highlights
AV-101, VistaGen's Oral NMDA Receptor Modulator, Granted FDA Fast-Track Designation for Major Depressive Disorder Key AV-101 Patents Issued .....»»
Intel Profit Surges on Growth in Data Center, PC Chip Businesses
A recovering personal-computer market and Intel’s growing data-center business helped the chip giant deliver strong results in the latest period, putting it on track to post a record year for profit and revenue......»»
Intel"s Strong Quarter Undercut by Concerns Over Chip Delay
A recovering personal-computer market and Intel’s growing data-center business helped the chip giant deliver strong results in the latest period, putting it on track to post a record year for profit and revenue......»»
Abercrombie & Fitch Co. Reports Third Quarter Results
Net sales increased to $861 million, despite adverse impacts from the calendar shift and foreign currency Comparable sales growth of 3%, on top of 4% last year Company remains on track to deliver top-line growth, gross profit rate .....»»
AMC Networks Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
AMC Networks (NASDAQ: AMCX) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2024. read more.....»»
SEI Investments to Report Q1 Results: Wall Street Expects Earnings Growth
SEI Investments (NASDAQ: SEIC) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2024. read more.....»»
Thinking About Buying Stock In Entera Bio, Allogene Or Vistagen?
Entera Bio Ltd (NASDAQ: ENTX) shares are trading higher by 3.3% at $3.10 Thursday morning after the company reported first-quarter sales results that showed year-over-year improvement. read more.....»»
Trading Statement And Business Performance Metrics For The Six Months Ended 31 December 2020
JOHANNESBURG, Jan. 29, 2021 /PRNewswire/ -- Sasol is expected to deliver a strong set of results for the six months ended 31 December 2020 (2021 financial half year), underpinned by a.....»»
Apple Earnings Preview: On Track To Top $100B Revenue Amid Strong Uptake Of iPhone 12
Apple Inc (NASDAQ: AAPL) is on track to report a bumper quarter, going by the iPhone sales trend. The company is scheduled to release its fiscal-year 2021 first-quarter results Wednesday after the market close.....»»
BeyondSpring Reports Fourth-Quarter and Full-Year 2019 Financial Results and Operational Update
- FDA Submission to Change the Primary Endpoint for Study 106 Phase 3 into an Industry First and Robust Clinical Measure to Evaluate Superiority in CIN - - Initiated NDA Rolling Submission for Plinabulin for CIN in China in Q1 2020 - - On Track.....»»
GENFIT Reports Full-Year 2019 Financial Results and Corporate Update
Topline interim results from Phase 3 clinical trial RESOLVE-IT expected by the end of May 2020 Cash position of €277MM as of December 31, 2019 (vs €207MM as of December 31, 2018) Significant milestones achieved i.....»»
Ocugen expects topline results for Phase 3 study of OCU300 by year-end
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Ocugen Provides Business Update and Full Year 2019 Financial Results
Over 95% planned enrollment completed in Phase 3 oGVHD study; topline results anticipated by end of 2020 Conference Call and Webcast Today at 8:30 a.m. ET.....»»
Cassava expects topline results for Phase 2b study of PTI-125 in mid-year 2020
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Cassava expects topline results from Phase 2b study of PTI-125 mid-year 2020
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
On Track Innovations Ltd. Reports Fourth Quarter & Full Year 2019 Financial Results
On Track Innovations Ltd. Reports Fourth Quarter & Full Year 2019 Financial Results.....»»
miRagen Reports Fourth Quarter and Full Year 2019 Financial Results
Completed enrollment of 37 patients in the Phase 2 SOLAR trial of cobomarsen in CTCL; expects to report topline data in Q3 2020 Completed initial pla.....»»